9OF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioRestorative Therapies Inc

Watchlist Manager

Watchlist

Price: 0.334 EUR -6.7% Market Closed

Market Cap: €2.3m

	BioRestorative Therapies Inc F:9OF	US
M	Magellan Financial Group Ltd F:NNA	AU
	Cellectis SA F:ZVA	FR

Profitability Summary

BioRestorative Therapies Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

54%

Negative Operating Margin

-4.350%

Negative 3Y Average Operating Margin

-6.895%

Operating Margin is Increasing

-15.154% > -4.350%

Negative Net Margin

-3.959%

Negative 3Y Average Net Margin

-5.509%

Net Margin is Increasing

-14.900% > -3.959%

Negative Free Cash Flow Margin

-3.032%

Negative 3Y Average Free Cash Flow Margin

-3.463%

Free Cash Flow Margin is Increasing

-5.400% > -3.032%

Negative ROE

-320%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.489%

Declining ROIC

-1.313% > -3.685%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.